Article thumbnail

Impact of a Multimodal Antimicrobial Stewardship Program on Pseudomonas aeruginosa Susceptibility and Antimicrobial Use in the Intensive Care Unit Setting

By Douglas Slain, Arif R. Sarwari, Karen O. Petros, Richard L. McKnight, Renee B. Sager, Charles J. Mullett, Alison Wilson, John G. Thomas, Kathryn Moffett, H. Carlton Palmer and Harakh V. Dedhia

Abstract

Objective. To study the impact of our multimodal antibiotic stewardship program on Pseudomonas aeruginosa susceptibility and antibiotic use in the intensive care unit (ICU) setting. Methods. Our stewardship program employed the key tenants of published antimicrobial stewardship guidelines. These included prospective audits with intervention and feedback, formulary restriction with preauthorization, educational conferences, guidelines for use, antimicrobial cycling, and de-escalation of therapy. ICU antibiotic use was measured and expressed as defined daily doses (DDD) per 1,000 patient-days. Results. Certain temporal relationships between antibiotic use and ICU resistance patterns appeared to be affected by our antibiotic stewardship program. In particular, the ICU use of intravenous ciprofloxacin and ceftazidime declined from 148 and 62.5 DDD/1,000 patient-days to 40.0 and 24.5, respectively, during 2004 to 2007. An increase in the use of these agents and resistance to these agents was witnessed during 2008–2010. Despite variability in antibiotic usage from the stewardship efforts, we were overall unable to show statistical relationships with P. aeruginosa resistance rate. Conclusion. Antibiotic resistance in the ICU setting is complex. Multimodal stewardship efforts attempt to prevent resistance, but such programs clearly have their limits

Topics: Clinical Study
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3113284
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). a n b e r g e r ,D .A r m a n ,H .G i l le ta l . ,“ S u rv e i l l a n c eo fm i c r o -bial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control,”
  2. (2010). Abdelraouf et al., “Prevalence, resistancemechanisms,andsusceptibility ofmultidrugresistant bloodstream isolates of Pseudomonas aeruginosa,”
  3. (2005). American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia,”American
  4. (2004). C o o k ,P .G .C a t r o u ,J .D .C h r i s t i e ,P .D .Y o u n g ,a n d
  5. (1998). Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial
  6. (2007). Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship,” Clinical Infectious Diseases,
  7. (2008). It’s time for a change in practice: reducing antibiotic use can alter antibiotic resistance,”
  8. (2010). Lack of increased colonization with vancomycinresistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated clostridium difficile infection,” Infection Control and Hospital Epidemiology,
  9. (2002). Multiple mechanisms of antimicrobial resistance inPseudomonasaeruginosa:our worstnightmare?”
  10. (2008). Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen,”
  11. (2008). Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome,”
  12. (2004). The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial,”